Cargando…
Prognostic Impact of 9-Month High-Sensitivity C-Reactive Protein Levels on Long-Term Clinical Outcomes and In-Stent Restenosis in Patients at 9 Months after Drug-Eluting Stent Implantation
INTRODUCTION: The level of 9-month high-sensitivity C-reactive protein (hsCRP) in predicting cardiovascular outcomes is scanty in patients at 9 months after receiving drug-eluting stent (DES) implantations. This study aims to evaluate the relationship between 9-month follow-up hsCRP levels and long-...
Autores principales: | Hsieh, I-Chang, Chen, Chun-Chi, Hsieh, Ming-Jer, Yang, Chia-Hung, Chen, Dong-Yi, Chang, Shang-Hung, Wang, Chao-Yung, Lee, Cheng-Hung, Tsai, Ming-Lung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583430/ https://www.ncbi.nlm.nih.gov/pubmed/26406989 http://dx.doi.org/10.1371/journal.pone.0138512 |
Ejemplares similares
-
Vessel Size and Long-Term Outcomes After Limus-Based Drug-Eluting Stent Implantation Focusing on Medium- and Small-Diameter Vessels
por: Hsieh, I-Chang, et al.
Publicado: (2016) -
Lesion Length Impacts Long Term Outcomes of Drug-Eluting Stents and Bare Metal Stents Differently
por: Chang, Shang-Hung, et al.
Publicado: (2013) -
Biodegradable Cable-Tie Rapamycin-eluting Stents
por: Lee, Cheng-Hung, et al.
Publicado: (2017) -
Promoting vascular healing using nanofibrous ticagrelor-eluting stents
por: Lee, Cheng-Hung, et al.
Publicado: (2018) -
Predictors of diffuse-type in-stent restenosis following drug-eluting stent implantation
por: PARK, CHANG-BUM, et al.
Publicado: (2013)